channel biacore t200 optical biosensor system (Biacore)
86
Structured Review
Biacore
channel biacore t200 optical biosensor system
Channel Biacore T200 Optical Biosensor System, supplied by Biacore, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t200+optical+biosensor/biacore+evaluation+software+t200/pmc12799113-147-6-7
Average 86 stars, based on 1 article reviews
Channel Biacore T200 Optical Biosensor System, supplied by Biacore, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t200+optical+biosensor/biacore+evaluation+software+t200/pmc12799113-147-6-7
Average 86 stars, based on 1 article reviews
channel biacore t200 optical biosensor system - by Bioz Stars,
2026-10
86/100 stars
Images
Related Articles
SPR Assay:Article Title: Discovery of natural catechol derivatives as covalent SARS-CoV-2 3CL pro inhibitors. Article Snippet: The COVID-19 pandemic caused by SARS-CoV-2 continues to pose a threat to public health, and extensive research by scientists worldwide has also prompted the development of antiviral therapies.. The 3C-like protease (3CLpro) is critical for SARS-CoV-2 replication and acts as an effective target for drug development.. To date, numerous of natural products have been reported to exhibit inhibitory effects on 3CLpro, which encourages us to identify other novel inhibitors and elucidate their mechanism of action. Article Title: Novel Para ‐Phenylenediamine‐Based Derivatives as Receptor Tyrosine Kinase‐like Orphan Receptor 1 (ROR1) Inhibitors: An In Vitro Preliminary Characterization Article Snippet: Recombinant human ROR1 protein (Fc Tag) and recombinant human ROR1 protein (aa 453‐783, His&GST Tag) were purchased from Elabscience (Texas, USA). .. SPR spectroscopy analyses were conducted to evaluate the binding affinity of the synthesized compounds against ROR1 receptor using a Article Title: Novel para-phenylenediamine-based derivatives as Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) Inhibitors: An in vitro preliminary characterization. Article Snippet: ROR1 kinase is an underexplored promising target for the development of novel anticancer drugs, being strongly expressed in several cancer cell lines, but poorly in non-tumor cells.. This property, together with the scarce number of molecules effective against ROR1, led us to design and develop a research program aimed to the discovery of new chemical entities able to inhibit ROR1 thus interfering with its pro-tumoral activity.. Step-by-step in silico studies guided the design and synthesis of para-phenylenediamine-based compounds. Article Title: Analytical and Functional Similarity of the Biosimilar Candidate ABP 654 to Ustekinumab Reference Product. Article Snippet: .. The relative binding to Fc gamma receptor type Ia (FcγRIa), IIa (FcγRIIa), IIb (FcγRIIb), and IIIb (FcγRIIIb) was characterized by SPR using a Article Title: Discovery of novel dual-target inhibitors of LSD1/EGFR for non-small cell lung cancer therapy. Article Snippet: The IC50 was calculated using a nonlinear regression (dose response – variable slope) by fitting the inhibition ratio and log of compound concentrations using Graphpad 8.0. .. SPR binding assay Surface plasmon resonance (SPR) was employed to evaluate direct binding between compounds and LSD1 using Article Title: Interferon beta antibodies and uses thereof Article Snippet: .. SPR was used to determine the KD of CTI-AF1 to human IFNβ; binding experiments were performed using a Control:Article Title: Discovery of natural catechol derivatives as covalent SARS-CoV-2 3CL pro inhibitors. Article Snippet: The COVID-19 pandemic caused by SARS-CoV-2 continues to pose a threat to public health, and extensive research by scientists worldwide has also prompted the development of antiviral therapies.. The 3C-like protease (3CLpro) is critical for SARS-CoV-2 replication and acts as an effective target for drug development.. To date, numerous of natural products have been reported to exhibit inhibitory effects on 3CLpro, which encourages us to identify other novel inhibitors and elucidate their mechanism of action. Spectroscopy:Article Title: Novel Para ‐Phenylenediamine‐Based Derivatives as Receptor Tyrosine Kinase‐like Orphan Receptor 1 (ROR1) Inhibitors: An In Vitro Preliminary Characterization Article Snippet: Recombinant human ROR1 protein (Fc Tag) and recombinant human ROR1 protein (aa 453‐783, His&GST Tag) were purchased from Elabscience (Texas, USA). .. SPR spectroscopy analyses were conducted to evaluate the binding affinity of the synthesized compounds against ROR1 receptor using a Article Title: Novel para-phenylenediamine-based derivatives as Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) Inhibitors: An in vitro preliminary characterization. Article Snippet: ROR1 kinase is an underexplored promising target for the development of novel anticancer drugs, being strongly expressed in several cancer cell lines, but poorly in non-tumor cells.. This property, together with the scarce number of molecules effective against ROR1, led us to design and develop a research program aimed to the discovery of new chemical entities able to inhibit ROR1 thus interfering with its pro-tumoral activity.. Step-by-step in silico studies guided the design and synthesis of para-phenylenediamine-based compounds. Binding Assay:Article Title: Novel Para ‐Phenylenediamine‐Based Derivatives as Receptor Tyrosine Kinase‐like Orphan Receptor 1 (ROR1) Inhibitors: An In Vitro Preliminary Characterization Article Snippet: Recombinant human ROR1 protein (Fc Tag) and recombinant human ROR1 protein (aa 453‐783, His&GST Tag) were purchased from Elabscience (Texas, USA). .. SPR spectroscopy analyses were conducted to evaluate the binding affinity of the synthesized compounds against ROR1 receptor using a Article Title: Analytical and Functional Similarity of the Biosimilar Candidate ABP 654 to Ustekinumab Reference Product. Article Snippet: .. 2.2.5 Binding Specificity Against Cytokines Related to IL‐23/IL‐12 The IL-23/IL-12 binding specificity was characterized for ABP 654 and ustekinumab RP using a Article Title: Novel para-phenylenediamine-based derivatives as Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) Inhibitors: An in vitro preliminary characterization. Article Snippet: ROR1 kinase is an underexplored promising target for the development of novel anticancer drugs, being strongly expressed in several cancer cell lines, but poorly in non-tumor cells.. This property, together with the scarce number of molecules effective against ROR1, led us to design and develop a research program aimed to the discovery of new chemical entities able to inhibit ROR1 thus interfering with its pro-tumoral activity.. Step-by-step in silico studies guided the design and synthesis of para-phenylenediamine-based compounds. Article Title: Analytical and Functional Similarity of the Biosimilar Candidate ABP 654 to Ustekinumab Reference Product. Article Snippet: .. The relative binding to Fc gamma receptor type Ia (FcγRIa), IIa (FcγRIIa), IIb (FcγRIIb), and IIIb (FcγRIIIb) was characterized by SPR using a Article Title: Discovery of novel dual-target inhibitors of LSD1/EGFR for non-small cell lung cancer therapy. Article Snippet: The IC50 was calculated using a nonlinear regression (dose response – variable slope) by fitting the inhibition ratio and log of compound concentrations using Graphpad 8.0. .. SPR binding assay Surface plasmon resonance (SPR) was employed to evaluate direct binding between compounds and LSD1 using Article Title: Interferon beta antibodies and uses thereof Article Snippet: .. SPR was used to determine the KD of CTI-AF1 to human IFNβ; binding experiments were performed using a Synthesized:Article Title: Novel Para ‐Phenylenediamine‐Based Derivatives as Receptor Tyrosine Kinase‐like Orphan Receptor 1 (ROR1) Inhibitors: An In Vitro Preliminary Characterization Article Snippet: Recombinant human ROR1 protein (Fc Tag) and recombinant human ROR1 protein (aa 453‐783, His&GST Tag) were purchased from Elabscience (Texas, USA). .. SPR spectroscopy analyses were conducted to evaluate the binding affinity of the synthesized compounds against ROR1 receptor using a Article Title: Novel para-phenylenediamine-based derivatives as Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) Inhibitors: An in vitro preliminary characterization. Article Snippet: ROR1 kinase is an underexplored promising target for the development of novel anticancer drugs, being strongly expressed in several cancer cell lines, but poorly in non-tumor cells.. This property, together with the scarce number of molecules effective against ROR1, led us to design and develop a research program aimed to the discovery of new chemical entities able to inhibit ROR1 thus interfering with its pro-tumoral activity.. Step-by-step in silico studies guided the design and synthesis of para-phenylenediamine-based compounds. |